Clinical Trials Directory

Safety and Efficacy of Open Study of Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment Resistant Bipolar Depression

We hope to learn whether this stimulation of neurons in the front part of the brain may relieve depression.

Stanford is not currently accepting new patients for this trial. You may want to check to see if other locations are recruiting.



  • device : MagStim

Phase: N/A


Ages Eligible For Study:

18 Years - N/A

Inclusion Criteria

Inclusion Criteria: - DSM IV Bipolar I or II Disorder with current major depressive episode - Prior failure to respond to or tolerate at least 2 adequate pharmacotherapy trials - Ham-D score greater than or equal to 18 Note: site enrolls only one patient per month

External Links

Contact information

Primary Contact:

Jessica Hawkins 6507238323

Stanford University School of Medicine 300 Pasteur Drive Stanford, CA 94305

Stanford Medicine Resources:

Footer Links: